Eflornithine hydrochloride is a pharmaceutical compound classified as an ornithine decarboxylase inhibitor, primarily indicated for the treatment of second-stage African trypanosomiasis and the reduction… Read more
Eflornithine hydrochloride is a pharmaceutical compound classified as an ornithine decarboxylase inhibitor, primarily indicated for the treatment of second-stage African trypanosomiasis and the reduction of unwanted facial hair in women. By inhibiting the synthesis of polyamines, this medication effectively slows parasite growth and cellular proliferation. Laboratories rely on high-quality reference standards for this active ingredient and its related substances to ensure precise analytical testing and method validation. This collection includes critical impurities, such as eflornithine lactam and various ester derivatives, which are essential for impurity profiling during manufacturing and stability studies. Furthermore, the inclusion of stable isotope labelled compounds provides researchers and quality control scientists with the internal standards necessary for accurate quantification in complex matrices, supporting rigorous regulatory compliance and the maintenance of product integrity throughout the pharmaceutical development lifecycle.